banner
You are not using a standards compliant browser. Because of this you may notice minor glitches in the rendering of this page. Please upgrade to a compliant browser for optimal viewing:
Firefox
Internet Explorer 7
Safari (Mac and PC)
Post Archive
2018 (0)2013 (2)2012 (29)
December (1)November (2)

Give thanks this Thursday—and always
Monday, November 19, 2012

"neuroBLOGical" turns 1!
Sunday, November 4, 2012
October (4)September (1)

Sight without seeing: Balint's syndrome
Sunday, September 16, 2012
August (2)

Catnip fever: why your cat acts high
Tuesday, August 28, 2012

Paralyze your face, fight depression
Wednesday, August 1, 2012
July (2)June (4)May (3)April (2)March (3)February (2)

Seeing into the future? The neuroscience of déjà vu
Sunday, February 26, 2012

Your love is my drug
Tuesday, February 14, 2012
January (3)
2011 (7)
Rate This Post
Total votes: 1
Blogger Profile

Jordan Gaines
Neuroscience
Pennsylvania State University USA

A blog on biology, psychology, cognition, learning, memory, aging, and everything in between. Explaining recent discoveries in neuroscience, translated to language we can all understand!

My posts are presented as opinion and commentary and do not represent the views of LabSpaces Productions, LLC, my employer, or my educational institution.

Blog RSS Feed
RSS Add to My Yahoo Add to Google
Recent Comments

Your blog is perhaps one of the best pieces of science writings I have recently come across! Brilliant work ! I have been meaning to start something similar..now am inspired :) By the way- . . .Read More
May 08, 2013, 2:08pm

When you get to smell, I have some burning questions.   What's the scoop on that new car smell, and why does it make you want to buy?  :)   . . .Read More
Jan 28, 2013, 7:14pm

Coolest series ever!  I can't wait for the next one. . . .Read More
Dec 10, 2012, 9:46am
Comment by Brian Krueger, PhD in "neuroBLOGical" turns 1!

I'm starting as the Associate Director of the Genomic Analysis Facility at Duke University in two weeks!  Hopefully once things settle down I'll actually be able to write again and start recruitin. . .Read More
Nov 06, 2012, 7:20am
Comment by Jordan Gaines in "neuroBLOGical" turns 1!

Excellent! What's the new job? . . .Read More
Nov 05, 2012, 5:37pm
Blogroll
Feb 01, 2011, 10:42am
Jan 07, 2011, 2:16pm
Monday, May 7, 2012

Montel Williams and 400,000 other Americans face it everyday. Richard Pryor was confined to a wheelchair in the last few years of his life because of it. Symptoms range from weakness to bladder problems to difficulty talking. Indeed, multiple sclerosis, or MS, is one of the most well-known yet mysterious neurological conditions we know about.

MS and myelin
MS is an inflammatory disorder affecting the central nervous system (brain/spinal cord) and its ability for nerve cells to communicate with one another.

Our individual nerve cells (neurons) have a fatty substance called myelin surrounding the long conducting axon fiber. If you picture the axon like an extremely long hot dog, myelin resembles hot dog buns lined up along its length.

Myelin allows neuron communication to occur much more rapidly. Instead of generating action potentials (rapid electrical changes) along each point in the axon, the action potential can "jump" over the myelin. Instead, action potentials are regenerated only at each node of Ranvier (see above), where there are breaks in the myelin sheath.

In MS, however, the body's immune system attacks the myelin sheath, causing it to break down and scar tissue to form. This process is called "demyelination." As a result, communication slows significantly. Check out these teased axon fibers showing progressive demyelination (the myelin is stained black):

So why is this happening?
Why exactly does the immune system attack myelin in MS? The cause is not well-understood, but some interesting correlations have been found. (Remember: correlation does not mean causation!)


Richard Pryor's 1995 cover of People magazine• While not hereditary, there is a greater risk of MS if a family member has it, and variations in particular genes have been linked to the disease.
• The further from the equator, the higher the incidence of MS—perhaps due to decreased sunlight and vitamin D production.
• Exposure to stress, smoking, and toxins may increase the risk.
• A number of microbes and viruses have been proposed as causes, but none have been definitively proven.


Diagnosis
Due to widespread demyelination in the central nervous system, symptoms vary greatly: numbness, tingling, weakness, difficulty with balance/coordination, trouble speaking/swallowing, visual problems, and pain. Typically, these symptoms occur in increasingly worsening episodes, called relapses; illness, stress, and pregnancy can make one more susceptible to relapse.

Because of this range of symptoms, MS is typically diagnosed via biopsy to examine signs of demyelination (like the image above). A lumbar puncture ("spinal tap") can also test cerebrospinal fluid for IgG, an inflammatory marker found in 75-85% of MS sufferers.

Treatment and...hope for regeneration?
Depending on the person's systems, a range of drugs—from pain relievers to mood stabilizers to bowel movement enhancers—may be prescribed. Physical activity, including aerobic exercise and strength/balance training, are particularly important for slowing disease progression. Even medical marijuana has been shown to improve symptoms of severe pain and muscle spasms.

In January, a paper published in Cell Stem Cell by Franklin Robin's group at Cambridge found that applying monocytes from young mice can rescue demyelination.

Advanced age decreases the ability for humans and animals to re-myelinate their neurons. This barrier poses a particular problem in the aging population suffering from MS, for which demyelination occurs.

Franklin and colleagues used a technique called "toxin-induced focal demyelination" in order to remove myelin in the spinal cord, resembling multiple sclerosis. Demyelinated mice receiving young monocytes (3rd panel, left) demonstrated significantly more myelination than demyelinated mice not receiving monocytes (2nd panel). In fact, this remyelination was comparable to what was seen in young control mice (compare 1st and 3rd panel.

Says Franklin, "For individuals with MS, this means that in theory regenerative therapies will work throughout the duration of the disease."

What's the best way to treat MS: prevent it? Treat the symptoms? Try to reverse the problem? Given that we don't know the cause, it's difficult to say. While a cure may not be imminent, life expectancy of sufferers is only 5-10 years less than non-sufferers these days—a drastic improvement from the past.

Images courtesy Intermountain Medical Imaging, Generic Look, and People.

Ruckh JM, Zhao JW, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, & Franklin RJ (2012). Rejuvenation of regeneration in the aging central nervous system. Cell stem cell, 10(1), 96-103 PMID: 22226359

This post has been viewed: 1956 time(s)

Tags:             

Blog Comments
No comments recorded.
Add Comment?
Comments are closed 2 weeks after initial post.
Friends